Open Day 1 of ESOC 2025 in Helsinki: OPTIMIST Trial Highlights
European Stroke Organisation (ESO) has shared an insightful post on X:
”Missed it live? Revisit Day 1 PI insights from ESOC 2025 in Helsinki. Investigators, moderated by Jelle De Meester and Teresa Ullberg, discuss the OPTIMIST main trial – nearly 5,000 patients, 114 hospitals, 8 countries.”
Watch the footage here.
Day 1 of ESOC 2025 in Helsinki featured key insights from the highly anticipated OPTIMIST main trial.
The trial was presented by principal investigators and moderated by Jelle De Meester and Teresa Ullberg.
The large-scale trial enrolled nearly 5,000 patients across 114 hospitals in 8 countries, offering robust data on stroke care optimization.
For those who missed the live session, the discussion provided critical updates on trial methodology, patient outcomes, and future directions in acute stroke management.
A must-watch for clinicians and researchers shaping the next generation of stroke care!
Hemostasis Today, your daily source of latest news on stroke management.
-
Mar 2, 2026, 17:22Hematologists and Oncologists Recognize Their Role in Specialized VA Care Despite Ongoing Knowledge Gaps – JTH
-
Mar 2, 2026, 17:04Fernando Corrales-Medina: An Evidence-Based Platform Promoting Early Recognition and Evaluation of VWD
-
Mar 2, 2026, 16:56Mbunya S. Misiani: Changing the Narrative on Bleeding Disorders Across Africa
-
Mar 2, 2026, 16:51Ofoke Chiamaka: Rehabilitation Is Not Just Muscle Training, It Is Brain Retraining
-
Mar 2, 2026, 16:41Paul Bolaji: Beyond Acute Stroke Care – Independent Integrated Living After Stroke
-
Mar 2, 2026, 16:37Gianluca Franceschini: Precision Medicine Is Only Truly Effective If It Is Inclusive
-
Mar 2, 2026, 16:34Maha Othman: Calling a Guest Editor for Current Opinion in Hematology
-
Mar 2, 2026, 16:30Tareq Abadl: Erythropoiesis – The Cellular Engineering Behind Oxygen Delivery
-
Mar 2, 2026, 16:28Tagreed Alkaltham: Blood Management in Times of Crisis